➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Cephalexin - Generic Drug Details

« Back to Dashboard

What are the generic sources for cephalexin and what is the scope of freedom to operate?

Cephalexin is the generic ingredient in five branded drugs marketed by Alkem Labs Ltd, Apothecon, Aurobindo Pharma Ltd, Barr, Belcher Pharms, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Orchid Hlthcare, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Yung Shin Pharm, Pragma, Hikma Pharms, Vitarine, Ranbaxy Labs Ltd, and Lilly, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for cephalexin. Thirty-five suppliers are listed for this compound.

Drug Prices for cephalexin

See drug prices for cephalexin

Drug Sales Revenue Trends for cephalexin

See drug sales revenues for cephalexin

Recent Clinical Trials for cephalexin

Identify potential brand extensions & 505(b)(2) entrants

University of California, Los AngelesPhase 4
Canadian Association of Emergency PhysiciansEarly Phase 1
The Ottawa Hospital Academic Medical AssociationEarly Phase 1

See all cephalexin clinical trials

Pharmacology for cephalexin
Medical Subject Heading (MeSH) Categories for cephalexin

US Patents and Regulatory Information for cephalexin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pragma KEFLEX cephalexin CAPSULE;ORAL 050405-005 May 12, 2006 AB RX Yes Yes   Get Started Free   Get Started Free   Get Started Free
Yoshitomi CEPHALEXIN cephalexin CAPSULE;ORAL 062872-001 Jun 20, 1988 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Ivax Sub Teva Pharms CEPHALEXIN cephalexin CAPSULE;ORAL 061969-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.